Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: NON-ALCOHOLIC FATTY LIVER DISEASE - METABOLISM , . Treffer: 13

2017

Fuchs, CD; Claudel, T; Scharnagl, H; Stojakovic, T; Trauner, M FXR controls CHOP expression in steatohepatitis.
FEBS Lett. 2017; 591(20):3360-3368 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Argo, CK; Ikura, Y; Lackner, C; Caldwell, SH The fat droplet in hepatocellular ballooning and implications for scoring nonalcoholic steatohepatitis therapeutic response.
Hepatology. 2016; 63(3):1056-1057 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Fengler, VH; Macheiner, T; Kessler, SM; Czepukojc, B; Gemperlein, K; Müller, R; Kiemer, AK; Magnes, C; Haybaeck, J; Lackner, C; Sargsyan, K Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
PLoS One. 2016; 11(5):e0155163-e0155163 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hartmann, P; Seebauer, CT; Mazagova, M; Horvath, A; Wang, L; Llorente, C; Varki, NM; Brandl, K; Ho, SB; Schnabl, B Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.
Am J Physiol Gastrointest Liver Physiol. 2016; 310(5):G310-G322 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Nawata, A; Noguchi, H; Mazaki, Y; Kurahashi, T; Izumi, H; Wang, KY; Guo, X; Uramoto, H; Kohno, K; Taniguchi, H; Tanaka, Y; Fujii, J; Sasaguri, Y; Tanimoto, A; Nakayama, T; Yamada, S Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease.
PLoS One. 2016; 11(4):e0152549-e0152549 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Argo, CK; Patrie, JT; Lackner, C; Henry, TD; de Lange, EE; Weltman, AL; Shah, NL; Al-Osaimi, AM; Pramoonjago, P; Jayakumar, S; Binder, LP; Simmons-Egolf, WD; Burks, SG; Bao, Y; Taylor, AG; Rodriguez, J; Caldwell, SH Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial.
J Hepatol. 2015; 62(1):190-197 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Beilfuss, A; Sowa, JP; Sydor, S; Beste, M; Bechmann, LP; Schlattjan, M; Syn, WK; Wedemeyer, I; Mathé, Z; Jochum, C; Gerken, G; Gieseler, RK; Canbay, A Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently.
Gut. 2015; 64(5):791-799
Web of Science PubMed FullText FullText_MUG

 

Healy, ME; Chow, JD; Byrne, FL; Breen, DS; Leitinger, N; Li, C; Lackner, C; Caldwell, SH; Hoehn, KL Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine.
J Hepatol. 2015; 62(3):599-606 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mueller, M; Thorell, A; Claudel, T; Jha, P; Koefeler, H; Lackner, C; Hoesel, B; Fauler, G; Stojakovic, T; Einarsson, C; Marschall, HU; Trauner, M Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
J Hepatol. 2015; 62(6):1398-1404 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Fuchs, CD; Claudel, T; Trauner, M Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD.
Trends Endocrinol Metab. 2014; 25(11):576-585
Web of Science PubMed FullText FullText_MUG

 

Kessler, SM; Simon, Y; Gemperlein, K; Gianmoena, K; Cadenas, C; Zimmer, V; Pokorny, J; Barghash, A; Helms, V; van Rooijen, N; Bohle, RM; Lammert, F; Hengstler, JG; Mueller, R; Haybaeck, J; Kiemer, AK Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
Int J Mol Sci. 2014; 15(4):5762-5773 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Simon, Y; Kessler, SM; Gemperlein, K; Bohle, RM; Müller, R; Haybaeck, J; Kiemer, AK Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
World J Gastroenterol. 2014; 20(47):17839-17850 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Valkovič, L; Gajdošík, M; Traussnigg, S; Wolf, P; Chmelík, M; Kienbacher, C; Bogner, W; Krebs, M; Trauner, M; Trattnig, S; Krššák, M Application of localized ³¹P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease.
Eur Radiol. 2014; 24(7): 1602-1609.
Web of Science PubMed FullText FullText_MUG

 

© Med Uni Graz Impressum